Cargando…
Postnatal oxytocin treatment improves survival and neurodevelopmental outcomes in an animal model of neonatal abstinence syndrome
Prenatal exposure to drugs of abuse results in neonatal abstinence syndrome (NAS). NAS causes significant morbidity and is associated with costly and lengthy hospitalization. Current pharmacotherapy is suboptimal with no FDA approved treatments. We examined the effect of postnatal oxytocin treatment...
Autores principales: | Carson, Dean S., Arnold, Simon J., Carson, Emily R.T., Pascual, Conrado, Xie, Xinmin (Simon) |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227985/ https://www.ncbi.nlm.nih.gov/pubmed/35757174 http://dx.doi.org/10.1016/j.cpnec.2022.100143 |
Ejemplares similares
-
Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome
por: Merhar, Stephanie L., et al.
Publicado: (2018) -
Postnatal surgery for myelomeningocele in neonates: neurodevelopmental outcomes
por: AKAR, Melek, et al.
Publicado: (2022) -
Postnatal calpeptin treatment causes hippocampal neurodevelopmental defects in neonatal rats
por: Song, Zhu-Jin, et al.
Publicado: (2019) -
Adolescent Oxytocin Exposure Causes Persistent Reductions in Anxiety and Alcohol Consumption and Enhances Sociability in Rats
por: Bowen, Michael T., et al.
Publicado: (2011) -
The Genomics of Neonatal Abstinence Syndrome
por: Cole, F. Sessions, et al.
Publicado: (2017)